Physician

Craig James Garofola, D.O.

According to 2025 Medicare claims, Craig Garofola, D.O. (NPI: 1861856056) practices dermatology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is VALLEY SKIN SPECIALISTS (NPI: 1588949234; TIN: 45-3483466) and primary practice location at 24018-1517. Garofola is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Garofola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,245 traditional Medicare patients, billed 6,713 HCPCS/CPT codes, and received $1,016,340 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 624 prescription claims across 309 beneficiaries totaling $264,310 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 46 records totaling $1,063. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $160,024 to $1,016,340. Similarly, Part D prescription costs have risen steadily, from $205 to $264,310. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$508K$1.0M2020 Medicare payment: $160,024 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $410,540 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $599,562 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $930,393 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,016,340 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204292,816$160,024
20219746,705$410,540
20229996,366$599,562
20231,4088,731$930,393
20241,2456,713$1,016,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$156K$311K2016 Drug cost: $205 (USD; Tot_Drug_Cst)2017 Drug cost: $2,770 (USD; Tot_Drug_Cst)2018 Drug cost: $10,032 (USD; Tot_Drug_Cst)2019 Drug cost: $57,109 (USD; Tot_Drug_Cst)2020 Drug cost: $32,533 (USD; Tot_Drug_Cst)2021 Drug cost: $62,740 (USD; Tot_Drug_Cst)2022 Drug cost: $100,737 (USD; Tot_Drug_Cst)2023 Drug cost: $311,432 (USD; Tot_Drug_Cst)2024 Drug cost: $264,310 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161423$205
20172450$2,770
201888150$10,032
201998197$57,109
2020228563$32,533
2021396908$62,740
2022399919$100,737
2023400851$311,432
2024309624$264,310

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks558755$439
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks281425$316
11102Biopsy of related skin growth, first growth331384$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more512640$56
17000Destruction of precancer skin growth, 1 growth293329$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab20546$81,293
Clobetasol PropionateClobetasol Propionate371,086$1,406
FluorouracilFluorouracil16369$1,374
KetoconazoleKetoconazole1003,042$1,272
MetronidazoleMetronidazole12387$746

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.46$1,063ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Craig James Garofola, D.O.?

Tedicare shows public-source Medicare data for Craig James Garofola, D.O. (NPI 1861856056), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Craig James Garofola, D.O. have ACO affiliation data?

Craig James Garofola, D.O. is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Craig James Garofola, D.O.?

Craig James Garofola, D.O. is linked to VALLEY SKIN SPECIALISTS (billing NPI 1588949234) in the available physician profile data.

Does Craig James Garofola, D.O. have Open Payments data?

Craig James Garofola, D.O. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.